Healthcare of Ontario Pension Plan Trust Fund Has $180.51 Million Position in HCA Healthcare, Inc. $HCA

Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5,941.1% in the 1st quarter, HoldingsChannel reports. The firm owned 381,433 shares of the company’s stock after buying an additional 375,119 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in HCA Healthcare were worth $180,509,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently modified their holdings of HCA. Brighton Jones LLC acquired a new position in HCA Healthcare in the 4th quarter valued at about $1,021,000. NewEdge Advisors LLC boosted its holdings in shares of HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after acquiring an additional 409 shares during the period. Sivia Capital Partners LLC increased its stake in shares of HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the period. Jump Financial LLC bought a new stake in HCA Healthcare in the 2nd quarter valued at $2,073,000. Finally, Sei Investments Co. increased its position in HCA Healthcare by 56.3% during the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after buying an additional 49,214 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA beat Q2 earnings estimates, reporting $7.59 per share versus expectations around $7.56-$7.57, while revenue rose 8.7% year over year to $20.23 billion and also topped estimates. HCA Healthcare earnings report
• Positive Sentiment: Management cited strong admissions and higher revenue per admission as key drivers of the quarter, suggesting healthy demand trends across its hospital network. Zacks article on HCA Q2 results
• Neutral Sentiment: HCA said its updated guidance is consistent with its earlier preview, so the quarter appears to confirm previously signaled results rather than deliver a major surprise. BusinessWire Q2 results
• Negative Sentiment: The company trimmed parts of its 2026 outlook, pointing to higher expenses and weaker surgical volumes as headwinds that could limit margin expansion. Zacks guidance revision article
• Negative Sentiment: Separate investor-law-firm investigations into HCA may add some legal overhang, though these notices are not operational results. Pomerantz investor alert

Analysts Set New Price Targets

HCA has been the topic of several research reports. Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a report on Tuesday, April 28th. Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Leerink Partners lowered their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Finally, Jefferies Financial Group set a $450.00 target price on HCA Healthcare in a research report on Tuesday, July 14th. Fourteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $483.45.

HCA Healthcare Trading Up 1.5%

NYSE HCA opened at $382.28 on Friday. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52. The firm has a market capitalization of $84.80 billion, a price-to-earnings ratio of 13.15, a P/E/G ratio of 1.27 and a beta of 1.12. The firm’s 50 day simple moving average is $386.95 and its 200 day simple moving average is $453.73.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same period in the prior year, the company earned $6.84 earnings per share. The company’s quarterly revenue was up 8.7% on a year-over-year basis. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 29.19 earnings per share for the current year.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.